Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers

NCT04446065 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

524

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV2

Interventions

DRUG: Previfenon®
DRUG: Placebo

Sponsor

MELISA Institute Genomics & Proteomics Research SpA

Collaborators

[object Object]